Why did Moderna’s Stock Decreased By 40% Despite Phase II Trials Starting?
Nimisha Agrawal
May 29, 2020
Ever Since from December 2018 when Moderna went public at $22, MRNA stock has only gone up until May 27 2020, when its price when down to about $52 that is 40% below its all –time high in May 18.
